The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Cardiol Therapeutics Inc (NASDAQ: CRDL) closed the day trading at $1.09 down -0.91% from the previous closing price of $1.1. In other words, the price has decreased by -$0.91 from its previous closing price. On the day, 1.67 million shares were traded. CRDL stock price reached its highest trading level at $1.19 during the session, while it also had its lowest trading level at $1.07.
Ratios:
For a better understanding of CRDL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.46 and its Current Ratio is at 2.46. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 02, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On January 28, 2025, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $7.
On June 26, 2024, ROTH MKM started tracking the stock assigning a Buy rating and target price of $10.ROTH MKM initiated its Buy rating on June 26, 2024, with a $10 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRDL now has a Market Capitalization of 92566512 and an Enterprise Value of 73212600.
Stock Price History:
The Beta on a monthly basis for CRDL is 0.96, which has changed by -0.42931938 over the last 52 weeks, in comparison to a change of 0.1716845 over the same period for the S&P500. Over the past 52 weeks, CRDL has reached a high of $2.63, while it has fallen to a 52-week low of $0.77. The 50-Day Moving Average of the stock is -14.89%, while the 200-Day Moving Average is calculated to be -13.40%.
Shares Statistics:
Over the past 3-months, CRDL traded about 666.78K shares per day on average, while over the past 10 days, CRDL traded about 807300 shares per day. A total of 82.67M shares are outstanding, with a floating share count of 78.70M. Insiders hold about 4.78% of the company’s shares, while institutions hold 7.96% stake in the company. Shares short for CRDL as of 1755216000 were 1867823 with a Short Ratio of 2.80, compared to 1752537600 on 1723937. Therefore, it implies a Short% of Shares Outstanding of 1867823 and a Short% of Float of 2.31.
Earnings Estimates
A detailed examination of Cardiol Therapeutics Inc (CRDL) is currently in progress, with 1 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.12 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.42 and -$0.42 for the fiscal current year, implying an average EPS of -$0.42. EPS for the following year is -$0.42, with 3.0 analysts recommending between -$0.3 and -$0.57.
